NCT00565084View on ClinicalTrials.gov

Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057)

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Osteoarthritis, Knee
Interventions
DRUG

ibuprofen

Patients will receive 800 mg ibuprofen in one of the three treatment periods.

DRUG

Placebo

Patients will receive placebo to ibuprofen in two of the three treatment periods.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00565084 - Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057) | Biotech Hunter | Biotech Hunter